Sign In
Buy TMCI
$3.69
+0.290 (+8.53%)
At Close: Jun 04, 2026
LOS ANGELES, CA / ACCESSWIRE / December 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon
The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
11:30am, Sunday, 29'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
01:45pm, Friday, 27'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
10:45am, Tuesday, 24'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
12:30pm, Saturday, 21'st Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
10:30am, Thursday, 19'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
01:30pm, Tuesday, 17'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
08:30am, Monday, 16'th Dec 2024
PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
